NovoCure Ltd

Overview

NovoCure Ltd (NovoCure) develops and commercializes novel delivery systems for the treatment of cancers of brain and abdomen. Its proprietary Tumor Treating Fields (TTF) technology platform uses electric fields tuned to specific frequencies for disrupting the division of solid tumor cancer cells. The company markets TTF-based delivery systems: Optune Lua for the treatment of malignant pleural mesothelioma; and Optune for the treatment of glioblastoma. Both products are indicated in combination with standard chemotherapies. Its product development and clinical programs strive to improve the survival of patients suffering from pancreatic cancer, brain metastases, ovarian cancer, liver cancer, gastric cancer, and non-small cell lung cancer. It has subsidiaries in Europe, the Middle East, Asia, and North America. NovoCure is headquartered in Saint Helier, Jersey, the UK.
Key Stats
Address
Forum, NO. 4 Grenville Street, SAINT HELIER, JE2 4UF, United Kingdom
Headquarters

United Kingdom

Contact

44 1534 756700

No of Employees

1,023

Industry

Medical Equipment

Ticker Symbol & Exchange​

NVCR [NASD]

Revenue (2020)

$494 m

40.6% (2020 vs 2019)
Net Income (2020)

$20 m

376.6% (2020 vs 2019)
Net Profit Margin

4 %

294.7% (2020 vs 2019)
Market Cap *

$14,095 m

EPS *

$0.1

  *Note: Ratios based on the share price as of 8-September-2021, in absolute numbers and US$.

Peer Comparison

Key Parameters NovoCure LtdHologic IncMDxHealth SAMagForce AG
Key Information
Headquarters United Kingdom United States of America Belgium Germany
Headquarter City SAINT HELIER MARLBOROUGH HERSTAL BERLIN
Headquarter State/Province - Massachusetts - -
No. of Employees 1,023 5,814 177 29
Entity Type Public Public Public Public

Products & Services

NovoCure develops and markets novel delivery systems built on its proprietary Tumor Treating Fields (TTF) technology for the treatment of cancers of brain and abdomen. Key marketed products and products under development of the company include the following:

Products
  • Optune Lua:
  • Malignant Pleural Mesothelioma
  • Optune:
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
Key Financial Charts
Sales Growth
Operating Margin
Net Income Growth
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets

Employees

Name Position Board Since Age Biography
William Burke Chief Human Resources Officer Senior Management 2021 - Mr. William Burke has been the Chief Human Resources Officer of the company since 2021. Most recently he served as...
Frank Leonard Chief Development Officer Senior Management 2020 - Mr. Frank Leonard serves as Chief Development Officer of the company since 2020. Prior to this, he served in various...
Wilhelmus Groenhuysen Chief Operating Officer Senior Management 2020 - Mr. Wilhelmus Groenhuysen serves as Chief Operating Officer of the company since 2020. Prior to this, he served as Chief...
Ashley Cordova Chief Financial Officer Senior Management 2020 - Ms. Ashley Cordova serves as Chief Financial Officer of the company since 2020. Prior to this, she served in various...
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.

History

Year Event Description
2021 Contracts/Agreements In May, the company and GT Medical Technologies entered into a clinical trial collaboration agreement…
2020 Contracts/Agreements In July, the company entered into a clinical trial collaboration agreement with Merck to develop…
2020 New Products/Services In June, the company launched MyLink, a new tool that allows patients to download their…
2020 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2020 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2019 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam

Locations


Novocure GmbH.
Novocure Netherlands BV
Novocure France SAS
Novocure Inc
Novocure Luxembourg Sarl
Novocure Canada Inc
Novocure Austria GmbH
Novocure Israel Ltd

Deals

Number of Deals
Deal Value (US$ m)

Latest Deals

Announced Date Headline Deal Type Acquirers / Investors / Surviving Entity Issuer / partner / Target
25 May 2021 NovoCure Enters into Clinical Trial Agreement with GT Medical Technologies Partnership GT Medical Technologies Inc; NovoCure Ltd
02 Nov 2020 Novocure Raises USD575 Million in Private Placement of 0% Convertible Notes Due 2025 Debt Offering NovoCure Ltd
15 Jul 2020 Novocure Enters into Agreement with Merck Partnership NovoCure Ltd; Merck & Co Inc
10 Sep 2018 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
30 Mar 2016 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
21 Sep 2015 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit

Jobs Overview

63

Active Jobs

20

Posted

22

Closed

Job Trends

Latest Jobs

Job title Company Country
Junior Planner, Global Supply Chain Readiness NovoCure Ltd India
Software Utilities Support Engineer NovoCure Ltd Israel
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar